1. Home
  2. ALLY vs EXAS Comparison

ALLY vs EXAS Comparison

Compare ALLY & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ally Financial Inc.

ALLY

Ally Financial Inc.

HOLD

Current Price

$42.69

Market Cap

12.9B

Sector

Finance

ML Signal

HOLD

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.08

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALLY
EXAS
Founded
1919
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
11.0B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
ALLY
EXAS
Price
$42.69
$101.08
Analyst Decision
Buy
Buy
Analyst Count
17
20
Target Price
$46.33
$76.38
AVG Volume (30 Days)
2.7M
10.3M
Earning Date
01-21-2026
11-03-2025
Dividend Yield
2.83%
N/A
EPS Growth
11.52
N/A
EPS
1.67
N/A
Revenue
$7,171,000,000.00
$3,082,033,000.00
Revenue This Year
$20.26
$19.40
Revenue Next Year
$14.12
$13.51
P/E Ratio
$25.36
N/A
Revenue Growth
6.02
14.47
52 Week Low
$29.52
$38.81
52 Week High
$44.83
$101.87

Technical Indicators

Market Signals
Indicator
ALLY
EXAS
Relative Strength Index (RSI) 64.17 89.74
Support Level $37.51 $100.98
Resistance Level $41.77 $101.43
Average True Range (ATR) 1.03 2.25
MACD 0.39 0.53
Stochastic Oscillator 93.52 97.74

Price Performance

Historical Comparison
ALLY
EXAS

About ALLY Ally Financial Inc.

Formerly the captive financial arm of General Motors, Ally Financial became an independent publicly traded firm in 2014 and is one of the largest consumer auto lenders in the country. While the firm has expanded its product offerings over time, it remains primarily focused on auto lending, with more than 70% of its loan book in consumer auto loans and dealer financing. Ally also offers auto insurance, commercial loans, credit cards, and holds a portfolio of mortgage debt, giving the bank a diversified business model, which includes brokerage services.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: